UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

UKAT operates a national network of Care Quality Commission (CQC)-regulated residential facilities, providing evidence-based treatment across addiction, mental health and long-term recovery. The acquisition is highly complementary to UKAT’s existing platform and supports its strategy to broaden its reach across behavioral health and complementary mental health services.

Bayberry provides personalized residential care for individuals seeking support for alcohol, drug and behavioral addictions, as well as a range of mental health and emotional wellbeing needs. Based in Warwickshire, UK, the company has established a strong reputation for discreet, high-quality care delivered in a calm and supportive environment. Its services support clients with trauma-related difficulties, anxiety, depression, burnout, neurodivergence, obsessive compulsive disorder (OCD)-related traits, psychosocial challenges and more complex emotional presentations.

Oaklins S&W, one of Oaklins’ member firms in the UK, acted as the buy-side advisor to UKAT and Sullivan Street Partners in this transaction. The deal further demonstrates Oaklins S&W’s specialist expertise in healthcare services and private equity-backed transactions, particularly in regulated and mission-critical sectors. The team had previously advised on the sale of The Providence Projects to UKAT.